The Boston Globe names Cubist to Globe 100's Top Places to Work '08
LEXINGTON, Mass. - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has been named one of the Top Places to Work in Massachusetts. In the debut of The Boston Globe 100's Top Places to Work, Cubist was ranked 36th on the overall list and 13th on the midsized company list. Four other life sciences companies were on the list published in the Sunday Globe on November 9th. Online, the report can be found at www.boston.com/topworkplaces.
Produced by the same team that compiles the 21-year-old Globe 100 report of the best-performing public companies in Massachusetts, the Top Places to Work recognizes the most progressive companies in the state based on employee opinions about company leadership, compensation and training, diversity/inclusion, career development, family-friendly flexibility, and values and ethics. Private companies and nonprofits as well as publicly-held businesses were included in the analysis.
The rankings in the Globe 100's Top Places to Work are based on survey information collected by Workplace Dynamics, an independent company specializing in employee engagement and retention, from 120,000 employees at about 600 Massachusetts organizations. This marks the first time that a Globe 100 report honors private as well as publicly-held organizations.
Cubist President and CEO Mike Bonney said, "This recognition from the Boston Globe is quite important for us. Making Cubist a great place to work is something we strive to do every day. Our continued success in developing and commercializing much needed acute care therapies depends on retaining and attracting the best and most highly motivated and committed scientific and business talent. Creating a positive work environment helps us achieve that end."
The publisher of The Boston Globe Steve Ainsley stated, "All the companies included in the Globe 100's Top Places to Work deserve a great deal of recognition. It's clear that they value their employees and make it a priority to create a positive workplace."
To qualify for the Globe 100's Top Places to Work, a company must have more than 100 employees in Massachusetts. Nearly 600 qualified companies accepted an invitation to participate. Rankings were composite scores calculated purely on the basis of employee responses.
Advertisement
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. Cubist has entered into an agreement with AstraZeneca to handle U.S. hospital sales for their established broad spectrum antibiotic, MERREM I.V.(R) (meropenem for injection). The Cubist product pipeline includes ecallantide, a recombinant human protein in Phase 2 clinical trials for the prevention of blood loss during cardiothoracic surgery, and pre-clinical programs that address unmet medical needs in Gram-negative infections, CDAD (Clostridium difficile-associated diarrhea), and HCV (Hepatitis C infections). Cubist is headquartered in Lexington, MA. Additional information can be found at Cubist's web site at www.cubist.com.
Cubist and CUBICIN are registered trademarks of Cubist Pharmaceuticals, Inc.